The Anschutz Medical Campus is a rich environment for training in clinical, translational and basic research methodologies relevant to Rheumatology.
Research on Campus
The CU Anschutz Medical Campus is a nationally recognized leader in the discovery and innovative approaches to improving human health. With research awards and gifts totaling more than $450 million annually, CU Anschutz researchers collaborate with partner and affiliate hospitals, clinics and centers to bring research from the bench to the patient’s bedside. Discoveries on the Anschutz Medical Campus have led to new medical devices, pharmaceuticals, diagnostic methods, treatment of debilitating conditions and improved quality of life for patients and consumers worldwide. Since 2002, CU Anschutz technology has led to the filing of 2,000 patent applications and the formation of 60 new companies, funded by more than $914 million in venture capital and public and private equity investment and grants.
The Colorado Clinical & Translational Sciences Institute
The CCTSI is the academic home to help transform the clinical and translational research and training efforts at the University of Colorado Anschutz Medical Campus and affiliated institutions. The CCTSI was created in 2008 with funding from the Clinical and Translational Science Award (CTSA) initiative of the National Institutes of Health (NIH) and is host to a wide range of Programs and Services supporting research and research training and mentoring, as well as a substantial portfolio of funding opportunities available to trainee and junior investigators.
The Human Immunology and Immunotherapy Initiative (HI3)
is a School of Medicine funded program to develop research infrastructure and provide experimental models for the preclinical testing of new candidate therapeutics, reliable immunotherapeutic production, consistent clinical trials research support, and organized immune monitoring capabilities. The HI3 supports recruitment and training of future scientific leaders within the realm of basic immunology and immunotherapy. The ultimate goal of the HI3 is to establish preeminence in human immune system-targeted therapies on the CU Anschutz medical campus.
The Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS) focuses on the spectrum of outcomes research, encompassing comparative effectiveness, patient-centered outcomes and implementation and dissemination research to guide clinical practice and policy. ACCORDS is organized into five programmatic areas: Dissemination and Implementation Science, Education, Research Training & Mentorship, Practice Transformation, and Community Engagement and Outreach, and also has methodologic cores in Qualitative Methods, Practice-Based Research Networks (PBRNs), Biostatistics, Patient-Centered Decisions and Mobile Health (mHealth) & Informatics. These cores provide support to the programmatic areas, as well as consultative support to investigators. A major focus of the methodological cores is to provide support for the development of new projects and grant proposals.
Master’s in Public Health
Fellows have the opportunity to pursue a Master’s in Public Health through the University of Colorado Denver. Tuition is not a standard component of fellowship support, but there are a number of support options available through training programs and grants. Many the core public health courses can be taken online, though some courses will require in-person attendance for day or on occasion evening courses. Students have up to 5 years to complete the program.
Further information can be found at the Colorado School of Public Health website.
Faculty Research Interests
Dr. Robert Fuhlbrigge MD PhD
Dr. Fuhlbrigge’s research activities are divided between basic science and clinical research interests. He maintains a lab focused on the study of fundamental immune mechanisms regulating the development and recurrence of inflammation in joints in both human and mouse models. His clinical science activities focus on juvenile localized scleroderma and developing a framework for performing comparative effectiveness research in this rare disease. Dr. Fuhlbrigge is also the current President of CARRA- the Childhood Arthritis and Rheumatology Research Alliance- through which he is engaged in a wide rand clinical and translational research projects and program development covering the spectrum of Pediatric Rheumatology.
Dr. Megan Curran MD
Dr. Curran’s scholarly interests reside in the fields of medical education and juvenile myositis. Her primary career goal is to increase the quality, quantity and availability of pediatric musculoskeletal and rheumatology education for trainees and healthcare providers. She has created a website called OuchMyLeg! for sharing educational materials. As a fellowship program director, she has helped organize national Pediatric Rheumatology objective structured clinical examinations (OSCE). Dr. Curran is involved in studying pediatric fellowship education topics at a national level, having coauthored publications about milestone evaluation with the Subspecialty Pediatrics Investigators Network (SPIN) and Association of Pediatric Program Directors (APPD). Dr. Curran is also interested in clinical research about juvenile inflammatory myopathies and has contributed to projects and publications about consensus treatment protocols through the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and patient outcomes through a large patient registry at Ann & Robert H. Lurie Children’s Hospital of Chicago.
Dr. Clara Lin MD
Dr. Lin is a nationally-recognized expert and instructor in the application of ultrasound to the diagnosis and treatment of pediatric musculoskeletal disorders. She is engaged in educational programming and curricular development in bedside ultrasound and supports a variety of research programs at Children’s Colorado.
Dr. Katherine Moore MD
Dr. Moore is a clinical research investigator and serves as site PI for the CARRA Registry and associated research studies and clinical trials. She is a core member of the CARRA Scleroderma Workgroup, which is directing clinical and translational research in both localized and systemic sclerosis in children
Dr. Jennifer Soep MD
Dr. Soep is engaged in scholarly activities within medical education. She is the site director for a national pilot project entitled, Education in Pediatrics Across the Continuum (EPAC). This is a study to test the feasibility of competency-based training across the continuum of medical school and residency. This project has also explored the use of reflection and narrative comments in learner assessments. As the Infant, Child and Adolescent Care Clerkship Director at University of Colorado School of Medicine, Dr. Soep has been involved in the development, implementation and evaluation of curricula in prescription writing and telephone triage and has participated in studying feedback and grading during clinical rotations. Nationally, Dr. Soep has been the co-leader for the Curriculum Task Force and Career Advising Collaborative within COMSEP (Council on Medical Student Education in Pediatrics) that is working to develop and study competency-based curricula and best practices for career advising of medical students pursuing pediatrics. Clinically, she has been involved with studies involving pediatric patients with Chronic Recurrent Multifocal Osteomyelitis and Antiphospholipid Antibody Syndrome.